Jiahui Yuan
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression.
Journal: Cell death & disease
Published: August 19, 2022
USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.
Journal: Cell biology and toxicology
Published: June 17, 2021
USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Journal: Molecular carcinogenesis
Published: November 04, 2020
Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
Journal: International journal of molecular sciences
Published: November 02, 2020
Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Journal: Cell death and differentiation
Published: June 20, 2020
Protective effects of iridoid glycosides on acute colitis via inhibition of the inflammatory response mediated by the STAT3/NF-кB pathway.
Journal: International immunopharmacology
Published: October 08, 2019
Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Journal: Medical oncology (Northwood, London, England)
Published: June 24, 2019
TNF-α and IFN-γ synergistically inhibit the repairing ability of mesenchymal stem cells on mice colitis and colon cancer.
Journal: American journal of translational research
Published: April 15, 2019
Corilagin induces apoptosis, autophagy and ROS generation in gastric cancer cells in vitro.
Journal: International journal of molecular medicine
Published: July 09, 2018
Corilagin inhibits breast cancer growth via reactive oxygen species-dependent apoptosis and autophagy.
Journal: Journal of cellular and molecular medicine
Published: July 25, 2017
Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NF-κB signaling by paracrine CCL5.
Journal: Oncotarget
Published: June 15, 2016
Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.
Journal: Oncotarget
Published: April 17, 2015
Last Updated: 09/26/2026